NCT01764776View on ClinicalTrials.gov

Effect of Hepatic Impairment on LDE225..

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Normal Hepatic FunctionImpaired Hepatic Function
Interventions
DRUG

LDE225

LDE225

Trial Locations (5)

1200

Novartis Investigative Site, Brussels

1612

Novartis Investigative Site, Sofia

14050

Novartis Investigative Site, Berlin

33136

University of Miami Div. of Clinical Pharmacology, Miami

64239

Novartis Investigative Site, Tel Aviv

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY